The ongoing deliberations by the U.S. Securities and Exchange Commission (SEC) on various applications for spot XRP exchange-traded funds (ETFs) continue to draw attention, as the agency has once again postponed making a final decision. Currently, 15 applications are awaiting review, and analysts remain optimistic that Ripple will secure its own spot ETF by year-end.
The most recent update pertains to the Franklin XRP ETF, which was submitted for SEC review in March. Initially, the SEC decided to delay a decision in April, indicating it required more input from both issuers and interested investors. By June, the agency had started formal proceedings to assess whether to approve or reject these applications. The SEC had set itself a 180-day timeline from the original submission date, with a deadline looming on September 15.
However, on September 10, the SEC announced a further extension of the review process, adding an additional 60 days. This pushes the new deadline for the Franklin XRP ETF decision to November 14, 2025. Meanwhile, most of the other XRP ETF applications have a deadline later in October this year.
Interestingly, despite this latest delay, XRP’s market price has shown resilience. Just today, the asset surged to just above $3 and has maintained this level following the announcement from the SEC.
Market sentiment remains largely favorable, as indicated by data from Polymarket. Analysts suggest that the probability of a spot XRP ETF gaining approval by the end of the year is currently estimated at over 90%. This aligns with the overall confidence in market perceptions regarding Ripple’s prospects in the ETF space.
In a related development, the SEC has taken a similar stance with another significant cryptocurrency ETF application, concerning staking for BlackRock’s ETH ETF, known as ETHA, demonstrating the agency’s cautious approach to approving new products in the digital asset sector.
In summary, while the SEC’s delays add uncertainty to the timeline for spot XRP ETFs, market analysts remain hopeful about imminent approvals and XRP’s ongoing performance appears unaffected in the face of regulatory challenges.
